Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents. 2012

Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

A series of eight novel podophyllotoxin derivatives were designed, synthesized and evaluated for biological activities. The antiproliferative activities were tested against a panel of human cancer cell lines (K562, SGC, Hela and HepG) and the inhibition of tubulin polymerization was also evaluated. Compound 8e displayed significant antiproliferative activities for all four cell lines and strong levels of tubulin polymerization inhibition effect. Combined with cell apoptosis and cell cycle analysis, it demonstrated that compound 3e that effectively interfere with tubulin dynamics prevent mitosis in cancer cells, leading to cell cycle arrest and, eventually dose dependent apoptosis. All experimental measurements were also supported by molecular docking simulations of colchicine binding site, which revealed the governing forces for the binding behavior and a good relationship with anti-tubulin activity and antiproliferative activities. The synthesis and biological studies provided an interesting new class of antitubulin agents for development of lead compounds and also a direction for further structure modification to obtain more potent anti-cancer drugs.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011034 Podophyllotoxin A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Epipodophyllotoxin,CPH86,Condyline,Condylox,Podocon-25,Podofilm,Podofilox,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer,Wartec,Warticon
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin

Related Publications

Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
August 2017, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
May 2012, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
January 2012, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
April 2017, Scientific reports,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
December 2010, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
February 2018, RSC advances,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
June 2005, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
August 2011, Bioorganic & medicinal chemistry,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
March 2014, Bioorganic & medicinal chemistry letters,
Yingqian Liu, and Dongfeng Wei, and Yonglong Zhao, and Weidong Cheng, and Yan Lu, and Yaqiong Ma, and Xin Li, and Chao Han, and Yanxia Wei, and Huiming Cao, and Chunyan Zhao
July 2005, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!